Comparison between GCM Securities IPO and HPC Biosciences IPO.
GCM Securities IPO is a SME Fixed Price IPO proposed to list at BSE SME while HPC Biosciences IPO is a SME Fixed Price proposed to list at BSE SME.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Oneview Corporate Advisors Pvt.Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Bindal Equities Ltd. | Narayan Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of GCM Securities IPO is up to ₹11.53 Cr whereas the issue size of the HPC Biosciences IPO is up to ₹15.15 Cr. The final issue price of GCM Securities IPO is ₹20.00 per share and of HPC Biosciences IPO is ₹35.00 per share.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹20.00 per share | ₹35.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 4000 shares |
| Fresh Issue Size | 57,66,000 shares | 43,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.53 Cr | up to ₹15.15 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,66,000 shares | 43,28,000 shares |
| Issue Size Total (Amount) | up to ₹11.53 Cr | up to ₹15.15 Cr |
GCM Securities IPO opens on Mar 18, 2013, while HPC Biosciences IPO opens on Mar 01, 2013. The closing date of GCM Securities IPO and HPC Biosciences IPO is Mar 20, 2013, and Mar 05, 2013, respectively.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 18, 2013 | Mar 01, 2013 |
| Issue Close | Mar 20, 2013 | Mar 05, 2013 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Apr 05, 2013 | Mar 19, 2013 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
GCM Securities IPO P/E ratio is , as compared to HPC Biosciences IPO P/E ratio of .
| GCM Securities IPO | HPC Biosciences IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 61.163 | 30.69 | ||||
| Promoter Shareholding (Post-Issue) | 41.55 | 22.01 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹37.98 Cr. | ₹55.65 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 2.59 | 63.53 |
In the GCM Securities IPO Retail Individual Investors (RII) are offered 28,80,000 shares while in HPC Biosciences IPO retail investors are offered 28,80,000 shares. Qualified Institutional Buyers (QIB) are offered in GCM Securities IPO and in HPC Biosciences IPO.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 3,30,000 shares | 2,32,000 shares |
| QIB | ||
| NII | 28,80,000 shares | 21,34,000 shares |
| RII | 28,80,000 shares | 21,34,000 shares |
| Employee | ||
| Others | ||
| Total | 57,60,000 shares | 42,68,000 shares |
GCM Securities IPO subscribed 2.54x in total, whereas HPC Biosciences IPO subscribed 1.09x.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.19x | 1.34x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.89x | 0.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.54x | 1.09x |
